Mototsugu Muramaki Selected Research

Mototsugu Muramaki Research Topics

Disease

28	Neoplasms (Cancer) 11/2020 - 11/2003
22	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 02/2005
14	Urinary Bladder Neoplasms (Bladder Cancer) 08/2010 - 11/2003
8	Neoplasm Metastasis (Metastasis) 11/2020 - 10/2004
8	Lymphatic Metastasis 12/2011 - 10/2004
7	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 10/2005
7	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2014 - 09/2003
5	Margins of Excision 11/2013 - 01/2006
4	Nonseminomatous germ cell tumor 10/2010 - 09/2004
4	Disease Progression 01/2006 - 05/2005
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 01/2013
2	Carcinoma (Carcinomatosis) 10/2020 - 12/2011
2	Choriocarcinoma 12/2014 - 10/2010
2	Extranodal Extension 07/2013 - 06/2010
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2013 - 02/2010
2	Hyperplasia 09/2008 - 08/2003
2	Testicular Neoplasms (Testicular Cancer) 07/2006 - 10/2004
2	Transitional Cell Carcinoma 01/2006 - 05/2005
1	Rheumatoid Arthritis 05/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2022
1	Adrenocortical Carcinoma 05/2022
1	Ureteral Obstruction 09/2020
1	Hypertension (High Blood Pressure) 01/2016
1	Postoperative Hemorrhage 06/2015
1	Infections 01/2014
1	Surgical Blood Loss 11/2013
1	Chronic Renal Insufficiency 01/2013
1	Non-Muscle Invasive Bladder Neoplasms 03/2012
1	Brain Neoplasms (Brain Tumor) 04/2011
1	Cerebral Hemorrhage 04/2011
1	Thyroiditis 09/2010
1	Hypothyroidism 09/2010

Drug/Important Bio-Agent (IBA)

8	Cisplatin (Platino)FDA LinkGeneric 12/2014 - 09/2003
8	ClusterinIBA 02/2010 - 02/2005
4	Prostate-Specific Antigen (Semenogelase)IBA 06/2010 - 01/2006
4	AndrogensIBA 09/2008 - 02/2005
3	Methotrexate (Mexate)FDA LinkGeneric 05/2022 - 04/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2014 - 01/2007
3	Antisense OligonucleotidesIBA 06/2011 - 09/2008
3	Therapeutic UsesIBA 03/2006 - 09/2005
3	Proteins (Proteins, Gene)FDA Link 10/2005 - 11/2003
3	OligodeoxyribonucleotidesIBA 05/2005 - 02/2005
3	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 03/2005 - 11/2003
2	Pharmaceutical PreparationsIBA 05/2022 - 07/2006
2	Angiogenesis InhibitorsIBA 11/2020 - 11/2003
2	OligonucleotidesIBA 05/2016 - 01/2007
2	C-Reactive ProteinIBA 01/2014 - 05/2009
2	Docetaxel (Taxotere)FDA Link 12/2012 - 03/2005
2	Cadherins (E-Cadherin)IBA 03/2012 - 12/2011
2	Etoposide (VP 16)FDA LinkGeneric 10/2010 - 12/2007
2	Biomarkers (Surrogate Marker)IBA 02/2010 - 01/2006
2	Gemcitabine FDA Link 02/2009 - 10/2004
2	Bleomycin (Blenoxane)FDA LinkGeneric 04/2008 - 12/2007
2	Tumor Biomarkers (Tumor Markers)IBA 12/2007 - 09/2005
2	HSP27 Heat-Shock ProteinsIBA 01/2007 - 03/2006
2	Insulin-Like PeptidesIBA 05/2005 - 02/2005
1	NivolumabIBA 11/2020
1	CreatinineIBA 01/2015
1	Ifosfamide FDA LinkGeneric 12/2014
1	ElementsIBA 12/2014
1	Sunitinib (Sutent)FDA Link 04/2011
1	Dactinomycin (Actinomycin)FDA LinkGeneric 10/2010
1	Sorafenib (BAY 43-9006)FDA Link 09/2010
1	Thyroid HormonesIBA 09/2010
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2010
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2010
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 09/2010
1	Pemetrexed (MTA)FDA Link 06/2010
1	Interleukin-2 (IL2)IBA 05/2009
1	Interferon-alpha (Interferon Alfa)IBA 05/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2009
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2009
1	Plasminogen Activator Inhibitor 1IBA 03/2009
1	Plasminogen Activator Inhibitor 2IBA 03/2009

Therapy/Procedure

19	Therapeutics 11/2020 - 11/2003
16	Prostatectomy (Retropubic Prostatectomy) 12/2014 - 09/2005
9	Drug Therapy (Chemotherapy) 12/2012 - 07/2004
8	Nephrectomy 06/2015 - 05/2009
5	Cystectomy 08/2010 - 05/2005
4	Adrenalectomy 05/2022 - 08/2003
4	Operative Time 06/2016 - 11/2013
4	Neoadjuvant Therapy 11/2013 - 11/2005
3	Warm Ischemia 06/2016 - 01/2015
3	Castration 05/2016 - 06/2011
3	Combination Drug Therapy (Combination Chemotherapy) 04/2008 - 09/2003
2	Stents 09/2020 - 01/2006
2	Induction Chemotherapy 12/2014 - 09/2004
2	Nephroureterectomy 12/2011 - 01/2008
2	Radiotherapy 04/2011 - 05/2005
2	Lymph Node Excision (Lymph Node Dissection) 02/2010 - 09/2004
2	Immunotherapy 05/2009 - 01/2004
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2006 - 07/2004
1	Metastasectomy 11/2020
1	Transurethral Resection of Bladder 10/2020
1	Duration of Therapy 01/2016
1	Solid-State Lasers 03/2013
1	Morcellation 03/2013
1	Aftercare (After-Treatment) 04/2011
1	MEA regimen 10/2010